Wishing you all a safe and happy end to 2024, and our very best wishes for a successful new year!
We look forward to continuing to work with you in 2025.
Our office closure dates
Australian offices 24 December 2024 to 2 January 2025, with significantly reduced staff numbers between.
IP Australia and IPONZ are also closed on 25 December, re-opening on Thursday 2 January 2025 (IP Australia) and Friday 3 January 2025 (IPONZ). Any deadline falling within a Patent Office closure period moves forward to its re-opening date. Should you need our urgent assistance during this time, please email [email protected].
Singapore, Malaysia, Philippines offices 25 December, 1 January
Indonesia and Hong Kong offices 25 December, 26 December, 1 January
Recent changes to China’s Anti-Unfair Competition Law reshape how businesses can use trade names, branding and search keywords. Practices that are commonly used in digital marketing now carry clearer…
Recent changes to China’s Anti-Unfair Competition Law reshape how businesses can use trade names, branding and search keywords. Practices…
In December 2025 the Australian Federal Court considered two applications for interlocutory (or preliminary) injunctions in branding disputes: Prezzee Pty Ltd v Epay Australia Pty Ltd FCA 1662 and Lindrum v T&P Lindrum Pty Ltd FCA 1644. Why was the…
In December 2025 the Australian Federal Court considered two applications for interlocutory (or preliminary) injunctions in branding disputes: Prezzee Pty Ltd v Epay Australia Pty Ltd FCA…
As a case involving virtual in-game items, the final ruling in the trade mark infringement and unfair competition dispute between Xuanwo Automotive Technology (Shanghai) Co., Ltd. (“Xuanwo”) and several…
As a case involving virtual in-game items, the final ruling in the trade mark infringement and unfair competition dispute…
“In China, there is no doctrine preventing an applicant from obtaining multiple patents for obvious variants, patentably indistinct subject matter, or incremental improvements, so long as the claims are…
“In China, there is no doctrine preventing an applicant from obtaining multiple patents for obvious variants, patentably indistinct subject…
